Inactive Instrument

Citicode Ltd. Stock Singapore S.E.

Equities

5FH

SG1Q38922098

Healthcare Facilities & Services

Sales 2022 34.14M 25.12M Sales 2023 32.92M 24.22M Capitalization 22.26M 16.37M
Net income 2022 3M 2.21M Net income 2023 - 0 EV / Sales 2022 1.4 x
Net Debt 2022 1.55M 1.14M Net Debt 2023 3.68M 2.71M EV / Sales 2023 0.79 x
P/E ratio 2022
15.3 x
P/E ratio 2023
30.8 x
Employees -
Yield 2022
0.83%
Yield 2023
-
Free-Float 22.2%
More Fundamentals * Assessed data
Dynamic Chart
Livingstone Health to Sell Over 55.5 Million Shares MT
Livingstone Health Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Livingstone Health's Net Profit to Drop Significantly in April-September MT
Livingstone Health Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Livingstone Health's Financial Controller Steps Down; Shares Drop 7% MT
Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller CI
Livingstone Health Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Livingstone Health's Head of Operations Resigns MT
Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations CI
Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend for the Financial Year Ended 31 March 2022, Payable on August 29, 2022 CI
Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend for the Financial Period Ended 31 March 2022, Payable on 11 August 2022 CI
Livingstone Teams Up with Osteopore to Develop 3D-Printed Solutions for Bone, Tissue Healing MT
Osteopore, Singaporean Healthcare Group Enter Deal to Develop New Regenerative Bone, Tissue Products MT
Osteopore Limited Signs Collaboration with Livingstone Health Holdings Limited to Develop New Products CI
Livingstone Health Issues Deferred Consideration Shares Related to RTO Deal MT
More news
Livingstone Health Holdings Limited is a Singapore-based investment holding company. The Company is engaged in the provision of medical treatment and consultancy services. The Company operates through six segments: Aesthetics and Wellness, Anaesthesiology and Pain Management, Family Medicine, Internal Medicine, Orthopaedic Surgery, and Others. Aesthetics and Wellness provides a range of services including laser and resurfacing therapies, radiofrequency, light and ultrasound-based treatments botulinum toxin and filler injections, chemical peels and various facial and body wellness treatments. Anaesthesiology and Pain Management provides comprehensive anesthetic services and perioperative care for a range of surgeries and procedures. Family Medicine provides vaccination and general medicine services; Internal Medicine provides cardiology and endocrinology services; and Orthopaedic surgery provides specialized care for patients with orthopedic problems.
More about the company